BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, May 12, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 25, 2005
View Archived Issues
Antiparkinsonian drug hemantane poised to start clinical trials
Read More
Update on the therapeutic benefits of anecortave in AMD
Read More
OSI-211 plus doxorubicin show promise as palliative therapy for advanced cancer
Read More
Antitumor effects reported for ZK-EPO in advanced cancer patients
Read More
Product highlights at AEterna Zentaris
Read More
UC Irvine awarded NIA grant for Alzheimer's disease
Read More
Johnson & Johnson's Risperdal for autism deemed not approvable by FDA
Read More
FDA approves extended shelf-life for Taxus Stent System
Read More
Ortho-McNeil licenses Cellzome small-molecule technology for Alzheimer's disease research
Read More
Progen commences phase II clinical trial of anticancer agent PI-88
Read More
Intercell directs E.U. effort in developing novel vaccine against Lyme borreliosis
Read More
Praecis reports major restructuring plan
Read More
Organon and Lexicon Genetics to codevelop biotherapeutics drugs
Read More
Geron cleared by FDA to commence clinical development of telomerase inhibitor for CLL
Read More
Tapestry initiates phase I clinical trial of TPI-287 in patients with taxane resistance
Read More
FDA grants Arginox cardiogenic shock drug orphan drug designation
Read More
CytRx seeks FDA approval to begin phase II clinical trials of ALS drug candidate
Read More
Epix submits response to FDA approvable letter for MRI contrast agent
Read More
PRECISE trial awaits first futility analysis recommendation
Read More
Studies describe activity and pharmacokinetics of regadenoson
Read More
Activity of lemuteporfin photodynamic therapy seen in LUTS patients
Read More
ZD-6474 combined with androgen ablation adds benefit in prostate cancer model
Read More
CNTO-328 demonstrates anticancer activity in animals and humans
Read More
Tesaglitazar improves abnormalities in nondiabetic patients with insulin resistance
Read More
Investigation of pasireotide progresses
Read More
ART-123 effective as postoperative thrombosis prophylaxis
Read More
Updated Coreg labeling approved by FDA
Read More
New anti-HIV agents described in recent patents
Read More
New treatments for type 2 diabetes reported
Read More
Novel ophthalmic agents disclosed by the University of Michigan
Read More